한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제27권3호
  • /
  • Pages.264-270
  • /
  • 2023
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지
DOI QR코드

DOI QR Code

Unconventional shunt surgery for non-cirrhotic portal hypertension in patients not suitable for proximal splenorenal shunt

  • Harilal, S L (Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)) ;
  • Biju Pottakkat (Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)) ;
  • Senthil Gnanasekaran (Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)) ;
  • Kalayarasan Raja (Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER))
  • 투고 : 2023.01.09
  • 심사 : 2023.04.05
  • 발행 : 2023.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Backgrounds/Aims: Proximal splenorenal shunt (PSRS) is a commonly performed procedure to decompress portal hypertension, in patients with refractory variceal bleed, especially in non-cirrhotic portal hypertension (NCPH). If conventional methods are hindered by any technical or pathological factors, alternative surgical techniques may be required. This study analyzes the effectiveness of various unconventional shunt surgeries performed for NCPH. Methods: A retrospective analysis of NCPH patients who underwent unconventional shunt surgeries during the period July 2011 to June 2022 was conducted. All patients were followed up for a minimum of 12 months with doppler study of the shunt to assess shunt patency, and upper gastrointestinal endoscopy to evaluate the regression of varices. Results: During the study period, 130 patients underwent shunt surgery; among these, 31 underwent unconventional shunts (splenoadrenal shunt [SAS], 12; interposition mesocaval shunt [iMCS], 8; interposition PSRS [iPSRS], 6; jejunal vein-cava shunt [JCS], 3; left gastroepiploic-renal shunt [LGERS], 2). The main indications for unconventional shunts were left renal vein aberration (SAS, 8/12), splenic vein narrowing (iMCS, 5/8), portalhypertensive vascular changes (iPSRS, 6/6), and portomesenteric thrombosis (JCS, 3/3). The median fall in portal pressure was more in SAS (12.1 mm Hg), and operative time more in JCS, 8.4 hours (range, 5-9 hours). During a median follow-up of 36 months (6-54 months), shunt thrombosis had been reported in all cases of LGERS, and less in SAS (3/12). Variceal regression rate was high in SAS, and least in LGERS. Hypersplenism had reversed in all patients, and 6/31 patients had a recurrent bleed. Conclusions: Unconventional shunt surgery is effective in patients unsuited for other shunts, especially PSRS, and it achieves the desired effects in a significant proportion of patients.

키워드

과제정보

The authors thank all residents who maintained portal hypertension data over 10 years in the Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

참고문헌

  1. Sarin SK, Sachdev G, Nanda R. Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg 1986;204:78-82. https://doi.org/10.1097/00000658-198607000-00011
  2. Poddar U, Thapa BR, Rao KL, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol 2008;23:1354-1357. https://doi.org/10.1111/j.1440-1746.2007.05102.x
  3. Prasad AS, Gupta S, Kohli V, Pande GK, Sahni P, Nundy S. Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg 1994;219:193-196. https://doi.org/10.1097/00000658-199402000-00011
  4. Gupta S, Pottakkat B, Verma SK, Kalayarasan R, Chandrasekar A S, Pillai AA. Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: its relevance in the management of portal hypertension. World J Gastrointest Surg 2020;12:1-8. https://doi.org/10.4240/wjgs.v12.i1.1
  5. Linton RR, Jones CM, Volwiler W. Portal hypertension; the treatment by splenectomy and splenorenal anastomosis with preservation of the kidney. Surg Clin North Am 1947;27:1162-1170. https://doi.org/10.1016/S0039-6109(16)32244-7
  6. Mazariegos GV, Reyes J. A technique for distal splenoadrenal shunting in pediatric portal hypertension. J Am Coll Surg 1998;187:634-636. https://doi.org/10.1016/S1072-7515(98)00244-0
  7. Gu S, Chang S, Chu J, Xu M, Yan Z, Liu DC, et al. Spleno-adrenal shunt: a novel alternative for portosystemic decompression in children with portal vein cavernous transformation. J Pediatr Surg 2012;47:2189-2193. https://doi.org/10.1016/j.jpedsurg.2012.09.007
  8. Gupta S, Srinivas GV, Chandrasekar AS, Kalayarasan R, Pottakkat B. Splenoadrenal shunt for noncirrhotic portal hypertension. Indian J Surg 2019;81:28-31. https://doi.org/10.1007/s12262-017-1706-z
  9. Drapanas T. Interposition mesocaval shunt for treatment of portal hypertension. Ann Surg 1972;176:435-448. https://doi.org/10.1097/00000658-197210000-00001
  10. Drapanas T, LoCicero J 3rd, Dowling JB. Hemodynamics of the interposition mesocaval shunt. Ann Surg 1975;181:523-533. https://doi.org/10.1097/00000658-197505000-00004
  11. Nyman UR, Semba CP, Chang H, Hoffman C, Dake MD. Percutaneous creation of a mesocaval shunt. J Vasc Interv Radiol 1996;7:769-773. https://doi.org/10.1016/S1051-0443(96)70847-3
  12. Moriarty JM, Kokabi N, Kee ST. Transvenous creation of a mesocaval shunt: report of use in the management of extrahepatic portal vein occlusion. J Vasc Interv Radiol 2012;23:565-567. https://doi.org/10.1016/j.jvir.2011.09.023
  13. Barman AA, Batiuchok W, Chaudry SS, Creedon JJ. Use of interposed polytetrafluorethylene (PTFE) graft in distal splenorenal shunt. Cardiovasc Dis 1981;8:555-557.
  14. Biju P, Midha K, Gupta S, Kalayarasan R, Gnanasekaran S. proximal splenorenal shunt in a rare renal vein anomaly: a case report. Cureus 2019;25:e4754.
  15. Sarfeh IJ, Rypins EB, Conroy RM, Mason GR. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983;197:422-426. https://doi.org/10.1097/00000658-198304000-00008
  16. Ellis DS, Linton RR, Jones CM. Effect of venous-shunt surgery on liver function in patients with portal hypertension; a follow-up study of 125 patients operated on in the last ten years. N Engl J Med 1956;254:931-936. https://doi.org/10.1056/NEJM195605172542002
  17. Warren WD, Henderson JM, Millikan WJ, Galambos JT, Bryan FC. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg 1988;207:623-634. https://doi.org/10.1097/00000658-198805000-00017